Skip to content

Prolotherapy: An Alternative for Knee Osteoarthritis

Prolotherapy in the treatment of knee osteoarthritis

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
REBEC
Registry ID
RBR-59ytd4c
Enrollment
Unknown
Registered
2025-03-11
Start date
2024-03-19
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee osteoarthritis

Interventions

This is a randomized, controlled clinical trial with three intervention arms, conducted with patients suffering from knee osteoarthritis. The study will be double-blind, with both patients and applica

Sponsors

Instituto Nacional de Traumatologia e Ortopedia
Lead Sponsor
Instituto Nacional de Traumatologia e Ortopedia
Collaborator

Eligibility

Age
40 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged between 40 and 75 years. Both sexes. Diagnosis of bilateral knee osteoarthritis according to the criteria of the American College of Rheumatology. Classified by radiographs using the Kellgren-Lawrence classification of grade III or less in both knees. Presenting with a full range of motion

Exclusion criteria

Exclusion criteria: Patients with a history of trauma, infection, or previous surgery in the affected joint. Patients with an alteration of the mechanical axis measurement of the lower limbs, varus or valgus greater than 5 degrees. Patients with inflammatory diseases. Corticosteroid infiltration in the last 6 weeks. Patients who underwent viscosupplementation in the past year. Patients who used NSAIDs in the two weeks prior. Patients with a body mass index greater than 40. Patients with a history of allergy to pollen or bird-derived products. Patients with active neoplasia

Design outcomes

Primary

MeasureTime frame
To compare the clinical outcomes of hyaluronic acid injection and prolotherapy in the conservative treatment of mild to moderate knee osteoarthritis

Secondary

MeasureTime frame
To standardize the treatment protocol for mild to moderate knee osteoarthritis with prolotherapy

Countries

Brazil

Contacts

Public ContactJosé Leonardo Rocha de Faria

Instituto Nacional de Traumatologia e Ortopedia

drjoseleonardorocha@gmail.com+55(21)21345554

Outcome results

None listed

Source: REBEC (via WHO ICTRP)